⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Study of Durvalumab Plus Tremelimumab as First-line Treatment in Chinese Patients With Unresectable Hepatocellular Carinoma

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Study of Durvalumab Plus Tremelimumab as First-line Treatment in Chinese Patients With Unresectable Hepatocellular Carinoma

Official Title: An Open-label, Multi-center Phase IIIb Study of Durvalumab and Tremelimumab as First-Line Treatment in Patients With Unresectable Hepatocellular Carcinoma

Study ID: NCT05557838

Study Description

Brief Summary: This is a prospective, open label, multi-center, interventional study to assess the safety and efficacy of Druvalumab plus Tremelimumab as first-line treatment in Chinese patients with unresectable hepatocellular carcinoma.

Detailed Description:

Keywords

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Research Site, Beijing, , China

Research Site, Beijing, , China

Research Site, Beijing, , China

Research Site, Beijing, , China

Research Site, Changsha, , China

Research Site, Changsha, , China

Research Site, Chengdu, , China

Research Site, Fuzhou, , China

Research Site, Guangzhou, , China

Research Site, Guangzhou, , China

Research Site, Guangzhou, , China

Research Site, Guangzhou, , China

Research Site, Hangzhou, , China

Research Site, Harbin, , China

Research Site, Ji Nan, , China

Research Site, Nanjing, , China

Research Site, Nanjing, , China

Research Site, Nanjing, , China

Research Site, Ningbo, , China

Research Site, Shanghai, , China

Research Site, Shanghai, , China

Research Site, Shenyang, , China

Research Site, Tianjin, , China

Research Site, Tianjin, , China

Research Site, Tianjin, , China

Research Site, Wenzhou, , China

Research Site, Wuhan, , China

Research Site, Wuhan, , China

Research Site, Xi'an, , China

Research Site, Zhangjiagang, , China

Research Site, Zhengzhou, , China

Research Site, Zhengzhou, , China

Contact Details

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: